Clinical Trial Update: Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST) [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of 20% and 100% autologous serum eye drops in patients with severe dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Autologous serum eye drops 100% (autologous serum eye drops)
• Autologous serum eye drops 20% (autologous serum eye drops)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Dry Eye Disease | NA | Status: COMPLETED